M&As this week: Terumo, DME Express, PENTAX Medical

3 August 2018 (Last Updated August 3rd, 2018 14:45)

Terumo Corporation has signed an agreement to purchase Essen Technology (Beijing) Co Ltd.

Terumo Corporation has signed an agreement to purchase Essen Technology (Beijing) Co Ltd.

Essen Technology will receive an upfront payment of CNY879m (129.67m) from Terumo as well as milestone payments contingent upon future performance, as part of the agreement.

The transaction is expected to be closed this year, subject to certain pre-conditions.

Terumo will fund the transaction through cash in hand.

Based in Japan, Terumo is a medical devices manufacturer, while Essen Technology is a China-based manufacturer and marketer of drug-eluting stents (DES).

The acquisition will enable the acquirer company to expand the sales of its drug-eluting stents in China.

DME Express has acquired Advanced Therapeutics for an undisclosed sum.

Based in the US, DME Express is a medical equipment solutions provider to hospice and nursing facilities, while Advanced Therapeutics, also based in the US, is a medical equipment provider for the subacute healthcare industry.

“The transaction enables the acquirer company to expand its hygiene portfolio and focus on the improvement of patient safety in endoscopy.”

The acquisition enables the acquirer company to expand its footprint in the US.

PENTAX Medical Co has completed the purchase of a majority stake in PlasmaBiotics SAS for an undisclosed consideration.

Based in the US, PENTAX Medical is a developer of medical imaging devices and a subsidiary of Hoya Group, while PlasmaBiotics is a France-based developer of devices used for the drying and storage of endoscopes.

The transaction enables the acquirer company to expand its hygiene portfolio and focus on the improvement of patient safety in endoscopy.

Hologic Inc has completed the acquisition of Faxitron Bioptics for $85m.

Based in the US, Hologic is a medical technology company focused on the development of women’s health products, while Faxitron Bioptics, also based in the US, is a manufacturer cabinet X-ray system for specimen radiography.

The transaction enables the acquirer company to strengthen its breast health product portfolio and provide targeted treatments for breast cancer patients.